Characterization of human uropathogenic ESBL-producing escherichia coli in the Czech Republic: Spread of CTX-M-27-producing strains in a university hospital

Microbial Drug Resistance

Volumn 20, Issue 6, 2014, Pages 610-617

  Micenková, Lenka ^a   Šišková, Petra ^b   Bosák, Juraj ^a   Jamborová, Ivana ^c   Cernohorská, Lenka ^b   Šmajs, David ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAMASE; CTX-M-27, E COLI; ESCHERICHIA COLI PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CZECH REPUBLIC; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; NONHUMAN; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; UNIVERSITY HOSPITAL; UROPATHOGENIC ESCHERICHIA COLI; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PROCEDURES; VIRULENCE;

ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CZECH REPUBLIC; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; VIRULENCE;

EID: 84915820519     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0013     Document Type: Article

References (62)

1. Azpiroz, M.F., M.E. Poey, and M. Laviñ a. 2009. Microcins and urovirulence in Escherichia coli. Microb. Pathog. 47:274-280.
2. Bingen, E., B. Picard, N. Brahimi, S. Mathy, P. Desjardins, J. Elion, and E. Denamur. 1998. Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J. Infect. Dis. 177:642-650.
3. Brosová, E., L. Siegfried, M. Kmetová , A. Makara, A. Ostró , A. Gresová, P. Urdźk, A. Liptáková, M. Moloka cová, R. Bártl, and L. Valanský. 2004. Detection of virulence factors in alpha-haemolytic Escherichia coli strains isolated from various clinical materials. Clin. Microbiol. Infect. 10:569-573.
4. Bradford, P.A. 2001. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
5. Briñ as, L., M. Zarazaga, Y. Saénz, F. Ruiz-Larrea, and C. Torres. 2002. Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob. Agents Chemother. 46: 3156-3163.
6. Carattoli, A., A. Garcá-Fernández, P. Varesi, D. Fortini, S. Gerardi, A. Penni, C. Mancini, and A. Giordano. 2008. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J. Clin. Microbiol. 46:103-108.
7. Carlos, C., M.M. Pires, N.C. Stoppe, E.M. Hachich, M.I. Sato, T.A. Gomes, L.A. Amaral, and L.M. Ottoboni. 2010. Escherichia coli phylogenetic group determination and its application in the identification of the major animal source of fecal contamination. BMC Microbiol. 10:161.
8. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
9. Clermont, O., H. Dhanji, M. Upton, T. Gibreel, A. Fox, D. Boyd D, M.R. Mulvey, P. Nordmann, E. Ruppé, J.L. Sarthou, T. Frank, S. Vimont, G. Arlet, C. Branger, N. Woodford, and E. Denamur. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
10. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement ed. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Coelho, A., A. Mora, R. Mamani, C. López, J.J. González-López, M.N. Larrosa, J.N. Quintero-Zarate, G. Dahbi, A. Herrera, J.E. Blanco, M. Blanco, M.P. Alonso, G. Prats, and J. Blanco. 2011. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J. Antimicrob. Chemother. 66:517-526.
13. Dáz, M.A., J.R. Hernández-Bello, J. Rodŕguez-Bañ o, L. Martnez-Martnez, J. Calvo, J. Blanco, A. Pascual, and Spanish Group for Nosocomial Infections (GEIH). 2010. Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study. J. Clin. Microbiol. 48:2840-2845.
14. Dolejska, M., E. Brhelova, H. Dobiasova, J. Krivdova, J. Jurankova, A. Sevcikova, L. Dubska, I. Literak, A. Cizek, M. Vavrina, L. Kutnikova, and J. Sterba. 2012. Dissemination of IncFII(K)-type plasmids in multiresistant CTX-M-15-producing Enterobacteriaceae isolates from children in hospital paediatric oncology wards. Int. J. Antimicrob. Agents. 40:510-515.
15. Edelstein, M., M. Pimkin, I. Palagin, I. Edelstein, and L. Stratchounski. 2003. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents Chemother. 47: 3724-3732.
16. Ewers, C., G. Li, H. Wilking, S. Kiessling, K. Alt, E.M. Antaó, C. Laturnus, I. Diehl, S. Glodde, T. Homeier, U. Böhnke, H. Steinrü ck, H.C. Philipp, and L.H. Wieler. 2007. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they Int. J. Med. Microbiol. 297:163-176.
17. Finlay, B.B., L.S. Frost, and W. Paranchych. 1984. Localization, cloning, and sequence determination of the conjugative plasmid ColB2 pilin gene. J. Bacteriol. 160:402-407.
18. Foxman, B., and P. Brown. 2003. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect. Dis. Clin. North Am. 17:227-241.
19. Geser, N., R. Stephan, B.M. Korczak, L. Beutin, and H. Hächler. 2012. Molecular identification of extendedspectrum-b-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob. Agents Chemother. 56:1609-1612.
20. Ho, P.L., W.W.N. Poon, S.L. Loke, M.S.T. Leung, K.H. Chow, R.C.W. Wong, K.S. Yip, E.L. Lai, K.W. Tsang, and CombAT study group. 2007. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J. Antimicrob. Chemother. 60:140-144.
21. Huang, T.D., P. Bogaerts, C. Berhin, A. Guisset, and Y. Glupczynski. 2010. Evaluation of brilliance ESBL agar, a novel chromogenic medium for detection of extendedspectrum-beta-lactamase-producing Enterobacteriaceae. J. Clin. Microbiol. 48:2091-2096.
22. Jeziorowski, A., and D.M. Gordon. 2007. Evolution of microcin V and colicin Ia plasmids in Escherichia coli. J. Bacteriol. 189:7045-7052.
23. Karim, A., L. Poirel, S. Nagarajan, and P. Nordmann. 2001. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201:237-241.
24. Knothe, H., P. Shah, V. Krcmery, M. Antal, and S. Mitsuhashi. 1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11:315-317.
25. Köhler, C.D., and U. Dobrindt. 2011. What defines extraintestinal pathogenic Escherichia coli Int. J. Med. Microbiol. 301:642-647.
26. Kuhnert, P., J. Hacker, I. Mü hldorfer, A.P. Burnens, J. Nicolet, and J. Frey. 1997. Detection system for Escherichia coli-specific virulence genes: absence of virulence determinants in B and C strains. Appl. Environ. Microbiol. 63:703-709.
27. Lartigue, M.F., C. Zinsius, A. Wenger, J. Bille, L. Poirel, and P. Nordmann. 2007. Extended-spectrum betalactamases of the CTX-M type now in Switzerland. Antimicrob. Agents Chemother. 51:2855-2860.
28. Livermore, D.M., R. Canton, M. Gniadkowski, P. Nordmann, G.M. Rossolini, G. Arlet, J. Ayala, T.M. Coque, I. Kern-Zdanowicz, F. Luzzaro, L. Poirel, and N. Woodford. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.
29. López-Saucedo, C., J.F. Cerna, N. Villegas-Sepulveda, R. Thompson, F.R. Velazquez, J. Torres, P.I. Tarr, and T. Estrada-Garcá. 2003. Single multiplex polymerase chain reaction to detect diverse loci associated with diarrheagenic Escherichia coli. Emerg. Infect. Dis. 9:127-131.
30. Markovska, R., I. Schneider, D. Ivanova, E. Keuleyan, T. Stoeva, M. Sredkova, B. Markova, K. Bojkova, R. Gergova, A. Bauernfeind, and I. Mitov. 2012. High prevalence of CTX-M-15-producing O25b-ST131 Escherichia coli clone in Bulgarian hospitals. Microb. Drug Resist. 18:390-395.
31. Martnez, J.L., M. Herrero, and V. de Lorenzo 1994. The organization of intercistronic regions of the aerobactin operon of pColV-K30 may account for the differential expression of the iucABCD iutA genes. J. Mol. Biol. 238:288-293.
32. Matsumura, Y., M. Yamamoto, T. Higuchi, T. Komori, F. Tsuboi, A. Hayashi, Y. Sugimoto, G. Hotta, A. Matsushima, M. Nagao, S. Takakura, and S. Ichiyama. 2012. Prevalence of plasmid-mediated AmpC b-lactamaseproducing Escherichia coli and spread of the ST131 clone among extended-spectrum b-lactamase-producing E. coli in Japan. Int. J. Antimicrob. Agents 40:158-162.
33. Micenková, L., B. Staudová, J. Bosák, L. Mikalová, S. Littnerová, M. Vrba, A. Sev-ćková, V. Woznicová, and D. Smajs. 2014. Bacteriocin-encoding genes and ExPEC virulence determinants are associated in human fecal Escherichia coli strains. BMC Microbiol. 14:109.
34. Mora, A., M. Blanco, C. López, R. Mamani, J.E. Blanco, M.P. Alonso, F. Garcá-Garrote, G. Dahbi, A. Herrera, A. Fernández, B. Fernández, A. Agulla, G. Bou, and J. Blanco. 2011. Emergence of clonal groups O1:HNM-DST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b: H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTXM-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int. J. Antimicrob. Agents 37:16-21.
35. Moreno, E., A. Andreu, T. Pérez, M. Sabaté, J.R. Johnson, and G. Prats. 2006. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol. Infect. 134:1015-1023.
36. Mugnaioli, C., F. Luzzaro, F. De Luca, G. Brigante, M. Perilli, G. Amicosante, S. Stefani, A. Toniolo, and G.M. Rossolini. 2006. CTX-M-type extended-spectrum betalactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob. Agents Chemother. 50:2700-2706.
37. Naseer, U., O.B. Natas, B.C. Haldorsen, B. Bue, H. Grundt, T.R. Walsh, and A. Sundsfjord. 2007. Nosocomial outbreak of CTX-M-15-producing E. coli in Norway. APMIS 115:120-126.
38. Navarro, F., R.J. Mesa, E. Miró, L. Gómez, B. Mirelis, and P. Coll. 2007. Evidence for convergent evolution of CTX-M-14 ESBL in Escherichia coli and its prevalence. FEMS Microbiol. Lett. 273:120-123.
39. Nicolas-Chanoine, M.H., J. Blanco, V. Leflon-Guibout, R. Demarty, M.P. Alonso, M.M. Canicą, Y.J. Park, J.P. Lavigne, J. Pitout, and J.R. Johnson. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
40. Oteo, J., K. Diestra, C. Juan, V. Bautista, A. Novais, M. Pérez-Vázquez, B. Moyá , E. Miró, T.M. Coque, A. Oliver, R. Cantón, F. Navarro, J. Campos, and Spanish Network in Infectious Pathology Project (REIPI). 2009. Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int. J. Antimicrob. Agents 34:173-176.
41. Paciorek, J. 2002. Virulence properties of Escherichia coli faecal strains isolated in Poland from healthy children and strains belonging to serogroups O18, O26, O44, O86, O126 and O127 isolated from children with diarrhoea. J. Med. Microbiol. 51:548-556.
42. Paton, A.W., and J.C. Paton. 1998. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J. Clin. Microbiol. 36:598-602.
43. Patzer, S.I., M.R. Baquero, D. Bravo, F. Moreno, and K. Hantke. 2003. The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology (Reading, Engl.) 149:2557-2570.
44. Peirano, G., and J.D.D. Pitout. 2010. Molecular epidemiology of Escherichia coli producing CTX-M betalactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316-321.
45. Pitout, J.D.D. 2012. Extraintestinal Pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front. Microbiol. 3:9.
46. Pitout, J.D.D., A. Hossain, and N.D. Hanson. 2004. Phenotypic and molecular detection of CTX-M-betalactamases produced by Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 42:5715-5721.
47. Roy, S., S. Mukherjee, A.K. Singh, and S. Basu. 2011. CTX-M-9 group extended-spectrum b-lactamases in neonatal stool isolates: emergence in India. Indian J. Med. Microbiol. 29:305-308.
48. Schmidt, H., C. Knop, S. Franke, S. Aleksic, J. Heesemann, and H. Karch. 1995. Development of PCR for screening of enteroaggregative Escherichia coli. J. Clin. Microbiol. 33:701-705.
49. Smajs, D., S.E. Karpathy, J. Smarda, and G.M. Weinstock. 2002. Colicins produced by the Escherichia fergusonii strains closely resemble colicins encoded by Escherichia coli. FEMS Microbiol. Lett. 208:259-262.
50. Smajs, D., L. Micenková, J. Smarda, M. Vrba, A. Sev-ćková, Z. Valisová, and V. Woznicová 2010. Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor. BMC Microbiol. 10:288.
51. Song, S., E.Y. Lee, E.M. Koh, H.S Ha, H.J. Jeong, I.K. Bae, and S.H. Jeong. 2009. Antibiotic resistance mechanisms of Escherichia coli isolates from urinary specimens. Korean J. Lab. Med. 29:17-24.
52. Stamm, W.E., T.M. Hooton, J.R. Johnson, C. Johnson, A. Stapleton, P.L. Roberts, S.L. Moseley, and S.D. Fihn. 1989. Urinary tract infections: from pathogenesis to treatment. J. Infect. Dis. 159:400-406.
53. Stoesser, N., D.W. Crook, C.E. Moore, R. Phetsouvanh, V. Chansamouth V, P.N. Newton, and N. Jones. 2012. Characteristics of CTX-M ESBL-producing Escherichia coli isolates from the Lao People's Democratic Republic, 2004-2009. J. Antimicrob. Chemother. 67:240-242.
54. Stürenburg, E., A. Kühn, D. Mack, and R. Laufs. 2004. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance. J. Antimicrob. Chemother. 54:406-409.
55. Sun, J., X. Liao, L. Li, Y. Yang, B. Liu, Y. Wang, H. Zhu, L. Zhu, C. Tu, and Y. Liu. 2011. Emergence of pandemic B2-O25b-ST131 Escherichia coli harbouring blaCTX-M-3, blaCTX-M-27 and qnrS1 genes. J. Med. Microbiol. 60:1711-1712.
56. Tausova, D., M. Dolejska, A. Cizek, L. Hanusova, J. Hrusakova, O. Svoboda, G. Camlik, and I. Literak. 2012. Escherichia coli with extended-spectrum b-lactamase and plasmid-mediated quinolone resistance genes in great cormorants and mallards in Central Europe. J. Antimicrob. Chemother. 67:1103-1107.
57. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
58. Thai, Q.K., and J. Pleiss. 2010. SHV lactamase engineering database: a reconciliation tool for SHV b-lactamases in public databases. BMC Genomics 11:563.
59. Woerther, P.L., C. Angebault, H. Jacquier, H.C. Hugede, A.C. Janssens, S. Sayadi, A. El Mniai, L. Armand-Lefè vre, E. Ruppé, F. Barbier, L. Raskine, A.L. Page, N. de Rekeneire, and A. Andremont. 2011. Massive increase, spread, and exchange of extended spectrum b-lactamaseencoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger. Clin. Infect. Dis. 53:677-685.
60. Woodford, N., A. Carattoli, E. Karisik, A. Underwood, M.J. Ellington, and D.M. Livermore. 2009. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob. Agents Chemother. 53:4472-4482.
61. Yamamoto, S., A. Terai, K. Yuri, H. Kurazono, Y. Takeda, and O. Yoshida. 1995. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol. Med. Microbiol. 12:85-90.
62. Ye, Q., Y. Lau, B. Liang, and S. Tian. 2011. Antimicrobial resistance, genotypic characterization and pulsed-field gel electrophoresis typing of extended spectrum b-lactamasesproducing clinical Escherichia coli strains in Macao, China. Chin. Med. J. 124:2701-2707.